Frequency of Deletions of EPCAM (TACSTD1) in MSH2-Associated Lynch Syndrome Cases

Lynch syndrome is an autosomal dominant cancer predisposition syndrome characterized by loss of function of DNA mismatch repair enzyme MLH1, MSH2, MSH6, or PMS2. Mutations in MLH1 and MSH2 account for ∼80% of the inherited cases. However, in up to 20% of cases suspected of having a germline mutation...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rumilla, Kandelaria, Schowalter, Karen V., Lindor, Noralane M., Thomas, Brittany C., Mensink, Kara A., Gallinger, Steven, Holter, Spring, Newcomb, Polly A., Potter, John D., Jenkins, Mark A., Hopper, John L., Long, Tiffany I., Weisenberger, Daniel J., Haile, Robert W., Casey, Graham, Laird, Peter W., Le Marchand, Loic, Thibodeau, Stephen N.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Investigative Pathology 2011
Konular:
Regular Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3069927/
https://ncbi.nlm.nih.gov/pubmed/21227399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jmoldx.2010.11.011
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller